Výsledky vyhledávání - Birgit Schoeberl
- Zobrazuji výsledky 1 - 15 z 15
-
1
-
2
Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles Autor Chiratidzo R. Chamboko, Wayde Veldman, Rolland Bantar Tata, Birgit Schoeberl, Özlem Taştan Bishop
Vydáno 2023Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies Autor Yu Zhou, Anne-Laure Goenaga, Brian D. Harms, Hao Zou, Jianlong Lou, Fraser Conrad, Gregory P. Adams, Birgit Schoeberl, Ulrik B. Nielsen, James D. Marks
Vydáno 2012Artigo -
10
An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation Autor Birgit Schoeberl, Anthony C. Faber, Danan Li, Mei‐Chih Liang, Katherine Crosby, Matthew Onsum, Olga Burenkova, Emily Pace, Zandra E. Walton, Lin Nie, Aaron Fulgham, Youngchul Song, Ulrik B. Nielsen, Jeffrey A. Engelman, Kwok‐Kin Wong
Vydáno 2010Artigo -
11
MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors Autor Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum, Sharlene Adams, Sergio Iadevaia, Jian Tang, Victoria Rimkunas, Lihui Xu, Neeraj Kohli, Rachel Rennard, Maja Razlog, Yang Jiao, Brian D. Harms, Kenneth J. Olivier, Birgit Schoeberl, Ulrik B. Nielsen, Alexey A. Lugovskoy
Vydáno 2013Artigo -
12
Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3 Autor Charlotte F. McDonagh, Alexandra Huhalov, Brian D. Harms, Sharlene Adams, Violette Paragas, Shinji Oyama, Bo Zhang, Lia Luus, Ryan Overland, Stephanie A. Nguyen, Jinming Gu, Neeraj Kohli, Matt Wallace, Michael J. Feldhaus, Arthur J. Kudla, Birgit Schoeberl, Ulrik B. Nielsen
Vydáno 2012Artigo -
13
An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells Autor Qing Sheng, Xinggang Liu, Eleanor Fleming, Karen Yuan, Huiying Piao, Jinyun Chen, Zeinab Moustafa, Roman K. Thomas, Heidi Greulich, Anna C. Schinzel, Sara Zaghlul, David Batt, Seth A. Ettenberg, Matthew Meyerson, Birgit Schoeberl, Andrew L. Kung, William C. Hahn, Ronny Drapkin, David M. Livingston, Joyce F. Liu
Vydáno 2010Artigo -
14
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer Autor Adam J. Camblin, Emily A. Pace, Sharlene Adams, Michael D. Curley, Victoria Rimkunas, Lin Nie, Gege Tan, Troy Bloom, Sergio Iadevaia, Jason Baum, Charlene Minx, Akos Czibere, Chrystal U. Louis, Daryl C. Drummond, Ulrik B. Nielsen, Birgit Schoeberl, J. Marc Pipas, Robert M. Straubinger, Vasileios Askoxylakis, Alexey A. Lugovskoy
Vydáno 2018Artigo -
15
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121) Autor Birgit Schoeberl, Art Kudla, Kristina Masson, Ashish Kalra, Michael Curley, Gregory J. Finn, Emily Pace, Brian D. Harms, Jaeyeon Kim, Kearns Jeff, Aaron Fulgham, Olga Burenkova, Viara Grantcharova, Defne Yarar, Violette Paragas, Jonathan B. Fitzgerald, Marisa J. Wainszelbaum, Kip A. West, Sara Mathews, Rachel Nering, Bambang S. Adiwijaya, Gabriela Garcia, Bill Kubasek, Victor Moyo, Akos Czibere, Ulrik B. Nielsen, Gavin MacBeath
Vydáno 2017Revisão
Vyhledávací nástroje:
Související témata
Cancer research
Biology
Cell biology
ERBB3
Receptor
Signal transduction
Cancer
Genetics
Internal medicine
Medicine
Neuregulin
Biochemistry
Epidermal growth factor receptor
ErbB
Immunology
Chemistry
PI3K/AKT/mTOR pathway
Pharmacology
Protein kinase B
Receptor tyrosine kinase
Gene
MAPK/ERK pathway
Antibody
Autocrine signalling
Breast cancer
Cell
Cell growth
Neuregulin 1
Activator (genetics)
Algorithm